Publicaciones en colaboración con investigadores/as de University of Tokyo (8)

2020

  1. Comparisons of Nonhyperemic Pressure Ratios: Predicting Functional Results of Coronary Revascularization Using Longitudinal Vessel Interrogation

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 22, pp. 2688-2698

2019

  1. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?

    Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 13, Núm. 4, pp. 2723-2725

  2. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential

    Cardiovascular Diabetology, Vol. 18, Núm. 1

2017

  1. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

    Annals of Oncology, Vol. 28, Núm. 10, pp. 2517-2525

2016

  1. Atypical hemolytic uremic syndrome (aHUS): Essential aspects of an accurate diagnosis

    Clinical Advances in Hematology and Oncology, Vol. 14, Núm. 11, pp. 2-15

2015

  1. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model

    Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773

2014

  1. Residual macrovascular risk in 2013: What have we learned?

    Cardiovascular Diabetology, Vol. 13, Núm. 1

2011

  1. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

    Journal of Clinical Oncology, Vol. 29, Núm. 18, pp. 2598-2607